Fresenius Raises 2026 Core EPS Outlook Following Strong Q3 Earnings Growth
Fresenius SE & Co. KGaA reported a strong third quarter, highlighted by a 15% year-over-year increase in core earnings per share (EPS) to €0.72. The company's revenue reached €5.803 billion, representing a 6% year-over-year growth rate and an organic revenue expansion of 5%. Driven by these robust quarterly results, the healthcare company has officially raised its core EPS outlook for fiscal year 2026. This upward revision reflects improved operational performance and provides positive momentum for investors monitoring the company's long-term profitability trajectory.
Topics: earnings guidance revenue growth